Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?

Hanafy, Amr Shaaban

Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated? [electronic resource] - Hepatology international Mar 2019 - 165-172 p. digital

Publication Type: Journal Article

1936-0541

10.1007/s12072-019-09933-8 doi


Adult
Antiviral Agents--adverse effects
Ascites--etiology
Carbamates
Drug Therapy, Combination
Esophageal and Gastric Varices--etiology
Female
Hepatic Encephalopathy--etiology
Hepatitis C, Chronic--complications
Humans
Imidazoles--therapeutic use
Liver Cirrhosis--complications
Male
Middle Aged
Patient Selection
Pyrrolidines
Quality of Life
RNA, Viral--blood
Ribavirin--therapeutic use
Severity of Illness Index
Sofosbuvir--therapeutic use
Survival Rate
Sustained Virologic Response
Ultrasonography
Valine--analogs & derivatives